Analysis of human mammary fibroadenoma by Ki-67 index in the follicular and luteal phases of menstrual cycle

Cell Proliferation

Volumn 42, Issue 2, 2009, Pages 241-247

  Rego, M F ^a   Navarrete, M A L H ^a   Facina, G ^a,b   Falzoni, R ^a   Silva, R ^a   Baracat, E C ^a   Nazario, A C P ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Rua Napoleão de Barros 715 70 Andar ^*  (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BREAST EPITHELIUM; BREAST FIBROADENOMA; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN TISSUE; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGE FACTORS; BREAST FEEDING; BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; FIBROADENOMA; FOLLICULAR PHASE; HUMANS; KI-67 ANTIGEN; LUTEAL PHASE; OBESITY; PROGESTERONE; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 62449269902     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2009.00590.x     Document Type: Article

References (49)

1. Alle KM, Moss J, Venegas RJ, Khalkhali I, Klein SR (1996) Conservative management of fibroadenoma of the breast. Br. J. Surg. 83, 992 993.
2. Greenberg R, Skornick Y, Kaplan O (1998) Management of breast fibroadenomas. J. Gen. Intern. Med. 13, 640 645.
3. Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA (1995) Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology 196, 123 134.
4. Tabar L, Dean PB, Tot T (2001) Teaching Atlas of Mammography, 2th edn, p. 248. New York : Thieme Medical Publications.
5. Rosen PP, Hoda SA (2006) Fibroepithelial neoplasms. In : Rosen PP, Hoda SA ed. Breast Pathology: Diagnosis by Needle Core Biopsy, 2th edn, p. 69. Philadelphia : Lippincott Williams & Wilkins.
6. Houssami N, Cheung MN, Dixon JM (2001) Fibroadenoma of the breast. Med. J. Aust. 174, 185 188.
7. Dent DM, Cant PJ (1989) Fibroadenoma. World J. Surg. 13, 706 710.
8. Dupont WD, Page DL, Parl FF, Vnencak-Jones CL, Plummer WD Jr., Rados MS, Schuyler PA (1994) Long-term risk of breast cancer in women with fibroadenoma. N. Engl. J. Med. 331, 10 15.
9. Pantanowitz L, Lyle S, Tahan SR (2002) Fibroadenoma of the eyelid. Am. J. Dermatopathol. 24, 225 229.
10. Solomon GJ, Shin SJ, Romanzi LJ (2006) A 65-year-old woman with a 'hemorrhoid': fibroadenoma of the anogenital region. Arch. Pathol. Lab. Med. 130, 30 32.
11. Carty NJ, Carter C, Rubin C, Ravichandran D, Royle GT, Taylor I (1995) Management of fibroadenoma of the breast. Ann. R. Coll. Surg. Engl. 77, 127 130.
12. Simomoto MM, Nazário AC, Gebrim LH, Simões MJ, Baracat EC, De Lima GR (1999) Morphometric analysis of the epithelium of mammary fibroadenomas during the proliferative and secretory phases of the menstrual cycle. Breast J. 5, 256 261.
13. Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 31, 13 20.
14. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133, 1710 1715.
15. Brown DC, Gatter KC (1990) Monoclonal antibody Ki-67; its use in histopathology. Histopathology 17, 489 503.
16. Goodson WH, Moore DH, Ljung BM, Chew K, Florendo C, Mayall B, Smith HS, Waldman FM (1998) The functional relationship between in vivo bromodeoxyuridine labeling index and Ki-67 proliferation index in human breast cancer. Breast Cancer Res. Treat. 49, 155 164.
17. Cattoretti G, Becker MH, Key G, Duchrow M, Schluter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB1 and MIB3) detect proliferating cells in microwave-processed formalin-fixed parafin sections. J. Pathol. 168, 357 363.
18. Parrado C, Falkmer UG, Hoog A, Falkmer S, Ahrens O, Rius F, Grimelius L (1996) A technique for automatic/interactive assessment of the proliferating fraction of neoplastic cells in solid tumors. A methodological study on the Ki-67 immunoreactive cells in human mammary carcinomas, including a comparison with the results of conventional S-phase fraction assessments by means of DNA cytometry. Gen. Diagn. Pathol. 141, 215 217.
19. Jansen RLH, Hupperets PS, Arends JW, Joosten-Achjanie SR, Volovics A, Schouten HC, Hillen HF (1998) MIB-1 labelling index is an independent prognostic marker in primary breast cancer. Br. J. Cancer 78, 460 465.
20. Van Dierendonck JH, Keijzer R, van de Velde CJ, Cornelisse CJ (1989) Nuclear distribution of the Ki-67 antigen during the cell cycle: comparison with growth fraction in human breast cancer cells. Cancer Res. 49, 2999 3006.
21. Verheijen R, Kuijpers HJ, van Driel R, Beck JL, van Dierendonck JH, Brakenhoff GJ, Ramaekers FC (1989) Ki-67 detects a nuclear matrix-associated proliferation-related antigen. II. Localization in mitotic cells and association with chromosomes. J. Cell Sci. 92, 531 540.
22. Kill IR (1996) Localisation of the Ki-67 antigen within the nucleolus. Evidence for a fibrillarin-deficient region of the dense fibrillar component. J. Cell Sci. 109, 1253 1263.
23. Starborg M, Gell K, Brundell E, Hoog C (1996) The murine Ki-67 cell proliferation antigen accumulates in the nucleolar and heterochromatic regions of interphase cells and at the periphery of the mitotic chromosomes in a process essential for cell cycle progression. J. Cell Sci. 109, 143 153.
24. Bridger JM, Kill IR, Lichter P (1998) Association of pKi-67 with satellite DNA of the human genome in early G1 cells. Chromosome Res. 6, 13 24.
25. Nazαrio ACP, De Lima GR, Simões MJ, Novo NF (1995) Cell kinetics of the human mammary lobule during the proliferative and secretory phase of the menstrual cycle. Bull. Assoc. Anat. 79, 23 27.
26. Navarrete MA, Maier CM, Falzoni R, Quadros LG, Lima GR, Baracat EC, Nazario AC (2005) Assessment of the proliferative, apoptotic and cellular renovation indices of the human mammary epithelium during the follicular and luteal phases of the menstrual cycle. Breast Cancer Res. 7, 306 313.
27. Israel R, Mishell DR Jr., Stone SC, Thorneycroft IH, Moyer DL (1972) Single luteal phase serum progesterone assay as an indicator of ovulation. Am. J. Obstet. Gynecol. 112, 1043 1046.
28. Speroff L, Fritz MA (2004) Clinical Gynecologic Endocrinology and Infertility, 7th edn. Philadelphia : Lippincott Williams & Wilkins.
29. Cericatto R, Pozzobon A, Morsch DM, Menke CH, Brum IS, Spritzer PM (2005) Estrogen receptor-α, bcl-2 and c-myc gene expression in fibroadenomas and adjacent normal breast: association with nodule size, hormonal and reproductive features. Steroids 70, 153 160.
30. Farr AG, Nakane PK (1981) Immunohistochemistry with enzyme labeled antibodies: a brief review. J. Imunnol. Methods 47, 129 144.
31. Elias JM (1982) Principles and Techniques in Diagnostic Histopathology: Developments in Imunohistochemistry and Enzyme Histochemistry. New York : Noyes Publications, EUA.
32. Eigèliené N, Härkönen P, Erkkola R (2006) Effects of estradiol and medroxyprogesterone acetate on morphology, proliferation and apoptosis of human breast tissue inorgan cultures. BMC Cancer 6, 246.
33. Nie NH et al 1975) Statistical Pachage for the Social Sciences. New York : McGraw-Hill Education.
34. Agresti A (2002) Categorical Data Analysis, 2th edn. New York : Wiley-Interscience.
35. Conover WJ (1980) Practical Nonparametric Statistics, 2th edn. New York : John Wiley & Sons.
36. De Boever J, Vandekerckhove D (1982) Benign breast disease: steroid concentrations. J. Steroid Biochem. 17, 338.
37. Wang DY, Fentiman IS (1985) Epidemiology and endocrinology of benign breast disease. Breast Cancer Res. Treat. 6, 5 36.
38. Kuttenn F, Fournier S, Durand JC, Mauvais-Jarvis P (1981) Estradiol and progesterone receptors in human breast fibroadenomas. J. Clin. Endocrinol. Metab. 52, 1225 1229.
39. Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H (1993) Clonal analysis of fibroadenoma and phyllodes tumor of the breast. Cancer Res. 53, 4071 4074.
40. Dietrich CU, Pandis N, Teixeira MR, Bardi G, Gerdes AM, Andersen JA, Heim S (1995) Chromosome abnormalities in benign hyperproliferative disorders of epithelial and stromal breast tissue. Int. J. Cancer 60, 49 53.
41. Franco N, Picard SF, Mege F, Arnould L, Lizard-Nacol S (2001) Absence of genetic abnormalities in fibroadenomas of the breast determinated at p53 gene mutations ant microsatellite alterations. Cancer Res. 61, 7955 7958.
42. Franco N, Arnould L, Mege F, Picard SF, Arveux P, Lizard-Nacol S (2003) Comparative analysis of molecular alterations in fibroadenomas associated or not with breast cancer. Arch. Surg. 138, 291 295.
43. Kuijper A, Buerger H, Simon R, Schaefer KL, Croonen A, Boecker W, Van Der Wall E, Van Diest JP (2002) Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay. J. Pathol. 197, 575 581.
44. Noguchi S, Aihara T, Koyama H, Motomura K, Inaji H, Imaoka S (1995) Clonal analysis of benign and malignant human breast tumors by means of polymerase chain reaction. Cancer Lett. 90, 57 63.
45. Dixon JM, Mansel RE (1994) ABC of breast diseases. Congenital problems and aberrations of normal breast development and involution. BMJ 309, 797 780.
46. Lellé RJ, Heidenreich W, Stauch G, Wecke I, Gerdes J (1987) Determination of growth fractions in benign breast disease (BBD) with monoclonal antibody Ki-67. J. Cancer Res. Clin. Oncol. 113, 73 77.
47. Maiorano E, Albrizio M (1995) Tubular adenoma of the breast: an immunohistochemical study of ten cases. Pathol. Res. Praxt. 191, 1222 1230.
48. Kaya R, Pestereli HE, Erdogan G, Gülkesen KH, Karaveli S (2001) Proliferating activity in differential diagnosis of benign phyllodes tumor and cellular fibroadenomas: is it helpful? Pathol. Oncol. Res. 7, 213 216.
49. Dixon JM (1991) Cystic disease and fibroadenoma of the breast: natural history and relation to breast cancer risk. Br. Med. Bull. 47, 258 271.